Recent Finacing
Recent Raise
Kunshan RiboQuark Pharmaceutical Technology is a clinical-stage Chinese-foreign joint venture developing siRNA-based therapeutics, led by its ocular neuroprotectant candidate QPI-1007.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Kunshan RiboQuark Pharmaceutical Technology.
